{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T18:12:29Z","timestamp":1778263949132,"version":"3.51.4"},"reference-count":41,"publisher":"The Endocrine Society","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,5,1]]},"DOI":"10.1210\/jc.2013-3734","type":"journal-article","created":{"date-parts":[[2014,1,29]],"date-time":"2014-01-29T16:57:47Z","timestamp":1391014667000},"page":"E754-E765","source":"Crossref","is-referenced-by-count":468,"title":["TERT Promoter Mutations Are a Major Indicator of Poor Outcome in Differentiated Thyroid Carcinomas"],"prefix":"10.1210","volume":"99","author":[{"given":"Miguel","family":"Melo","sequence":"first","affiliation":[{"name":"Institute of Molecular Pathology and Immunology of the University of Porto (M.Me., A.G.d.R., J.V., R.B., J.P., C.T., R.C., A.A., C.S., C.E., P.C., H.P., J.L., V.M., M.S.-S., P.S.), 4200-465 Porto, Portugal"},{"name":"Departments of Endocrinology, Diabetes, and Metabolism (M.Me., F.C., M.C.), 3000-075 Coimbra, Portugal"},{"name":"Unit of Endocrinology (M.Me., M.C.), Faculty of Medicine, University of Coimbra, 3000-548 Coimbra, Portugal"}]},{"given":"Adriana Gaspar","family":"da Rocha","sequence":"additional","affiliation":[{"name":"Institute of Molecular Pathology and Immunology of the University of Porto (M.Me., A.G.d.R., J.V., R.B., J.P., C.T., R.C., A.A., C.S., C.E., P.C., H.P., J.L., V.M., M.S.-S., P.S.), 4200-465 Porto, Portugal"},{"name":"Medical Faculty, University of Porto (A.G.d.R., C.T.), 4200-139 Porto, Portugal"}]},{"given":"Jo\u00e3o","family":"Vinagre","sequence":"additional","affiliation":[{"name":"Institute of Molecular Pathology and Immunology of the University of Porto (M.Me., A.G.d.R., J.V., R.B., J.P., C.T., R.C., A.A., C.S., C.E., P.C., H.P., J.L., V.M., M.S.-S., P.S.), 4200-465 Porto, Portugal"},{"name":"Institute of Biomedical Sciences of Abel Salazar, University of Porto (J.V., A.A.), 4050-313 Porto, Portugal"}]},{"given":"Rui","family":"Batista","sequence":"additional","affiliation":[{"name":"Institute of Molecular Pathology and Immunology of the University of Porto (M.Me., A.G.d.R., J.V., R.B., J.P., C.T., R.C., A.A., C.S., C.E., P.C., H.P., J.L., V.M., M.S.-S., P.S.), 4200-465 Porto, Portugal"}]},{"given":"Joana","family":"Peixoto","sequence":"additional","affiliation":[{"name":"Institute of Molecular Pathology and Immunology of the University of Porto (M.Me., A.G.d.R., J.V., R.B., J.P., C.T., R.C., A.A., C.S., C.E., P.C., H.P., J.L., V.M., M.S.-S., P.S.), 4200-465 Porto, Portugal"}]},{"given":"Catarina","family":"Tavares","sequence":"additional","affiliation":[{"name":"Institute of Molecular Pathology and Immunology of the University of Porto (M.Me., A.G.d.R., J.V., R.B., J.P., C.T., R.C., A.A., C.S., C.E., P.C., H.P., J.L., V.M., M.S.-S., P.S.), 4200-465 Porto, Portugal"},{"name":"Medical Faculty, University of Porto (A.G.d.R., C.T.), 4200-139 Porto, Portugal"}]},{"given":"Ricardo","family":"Celestino","sequence":"additional","affiliation":[{"name":"Institute of Molecular Pathology and Immunology of the University of Porto (M.Me., A.G.d.R., J.V., R.B., J.P., C.T., R.C., A.A., C.S., C.E., P.C., H.P., J.L., V.M., M.S.-S., P.S.), 4200-465 Porto, Portugal"},{"name":"School of Allied Health Sciences, ESTSP - Escola Superior de Tecnologia da Sa\u00fade do Porto (R.C.), Polytechnic of Porto, 4400-330 Vila Nova de Gaia, Portugal"}]},{"given":"Ana","family":"Almeida","sequence":"additional","affiliation":[{"name":"Institute of Molecular Pathology and Immunology of the University of Porto (M.Me., A.G.d.R., J.V., R.B., J.P., C.T., R.C., A.A., C.S., C.E., P.C., H.P., J.L., V.M., M.S.-S., P.S.), 4200-465 Porto, Portugal"},{"name":"Institute of Biomedical Sciences of Abel Salazar, University of Porto (J.V., A.A.), 4050-313 Porto, Portugal"}]},{"given":"Catarina","family":"Salgado","sequence":"additional","affiliation":[{"name":"Institute of Molecular Pathology and Immunology of the University of Porto (M.Me., A.G.d.R., J.V., R.B., J.P., C.T., R.C., A.A., C.S., C.E., P.C., H.P., J.L., V.M., M.S.-S., P.S.), 4200-465 Porto, Portugal"}]},{"given":"Catarina","family":"Eloy","sequence":"additional","affiliation":[{"name":"Institute of Molecular Pathology and Immunology of the University of Porto (M.Me., A.G.d.R., J.V., R.B., J.P., C.T., R.C., A.A., C.S., C.E., P.C., H.P., J.L., V.M., M.S.-S., P.S.), 4200-465 Porto, Portugal"}]},{"given":"Patr\u00edcia","family":"Castro","sequence":"additional","affiliation":[{"name":"Institute of Molecular Pathology and Immunology of the University of Porto (M.Me., A.G.d.R., J.V., R.B., J.P., C.T., R.C., A.A., C.S., C.E., P.C., H.P., J.L., V.M., M.S.-S., P.S.), 4200-465 Porto, Portugal"}]},{"given":"Hugo","family":"Prazeres","sequence":"additional","affiliation":[{"name":"Institute of Molecular Pathology and Immunology of the University of Porto (M.Me., A.G.d.R., J.V., R.B., J.P., C.T., R.C., A.A., C.S., C.E., P.C., H.P., J.L., V.M., M.S.-S., P.S.), 4200-465 Porto, Portugal"},{"name":"Portuguese Institute of Oncology (H.P.), Coimbra Center, 3000-075 Coimbra, Portugal"}]},{"given":"Jorge","family":"Lima","sequence":"additional","affiliation":[{"name":"Institute of Molecular Pathology and Immunology of the University of Porto (M.Me., A.G.d.R., J.V., R.B., J.P., C.T., R.C., A.A., C.S., C.E., P.C., H.P., J.L., V.M., M.S.-S., P.S.), 4200-465 Porto, Portugal"}]},{"given":"Teresina","family":"Amaro","sequence":"additional","affiliation":[{"name":"Department of Pathology (T.A.), Hospital Pedro Hispano, 4464-513 Matosinhos, Portugal"}]},{"given":"Cl\u00e1udia","family":"Lobo","sequence":"additional","affiliation":[{"name":"Department of Pathology (C.L.), Portuguese Institute of Oncology, Porto Center, 4200-072 Porto, Portugal"}]},{"given":"Maria Jo\u00e3o","family":"Martins","sequence":"additional","affiliation":[{"name":"Pathology (M.J.M.), University and Hospital Center of Coimbra, 3000-075 Coimbra, Portugal"}]},{"given":"Margarida","family":"Moura","sequence":"additional","affiliation":[{"name":"Center for Investigation of Molecular Pathobiology (M.Mo., B.C., V.L.), 1099-023 Lisbon, Portugal"},{"name":"Center for the Study of Chronic Diseases (M.Mo., B.C., V.L.), Faculty of Medical Sciences, University of Lisbon, 1099-085 Lisbon, Portugal"}]},{"given":"Branca","family":"Cavaco","sequence":"additional","affiliation":[{"name":"Center for Investigation of Molecular Pathobiology (M.Mo., B.C., V.L.), 1099-023 Lisbon, Portugal"},{"name":"Center for the Study of Chronic Diseases (M.Mo., B.C., V.L.), Faculty of Medical Sciences, University of Lisbon, 1099-085 Lisbon, Portugal"}]},{"given":"Valeriano","family":"Leite","sequence":"additional","affiliation":[{"name":"Center for Investigation of Molecular Pathobiology (M.Mo., B.C., V.L.), 1099-023 Lisbon, Portugal"},{"name":"Department of Endocrinology (V.L.), Portuguese Institute of Oncology, Lisbon Center, 1099-023 Lisbon, Portugal"},{"name":"Center for the Study of Chronic Diseases (M.Mo., B.C., V.L.), Faculty of Medical Sciences, University of Lisbon, 1099-085 Lisbon, Portugal"}]},{"given":"Jos\u00e9 Manuel","family":"Cameselle-Teijeiro","sequence":"additional","affiliation":[{"name":"Department of Pathology (J.M.C.-T.), Clinical University Hospital, Servicio Gallego de Salud - SERGAS, Medical Faculty, University of Santiago de Compostela, 15705 Santiago de Compostela, Spain"}]},{"given":"Francisco","family":"Carrilho","sequence":"additional","affiliation":[{"name":"Departments of Endocrinology, Diabetes, and Metabolism (M.Me., F.C., M.C.), 3000-075 Coimbra, Portugal"}]},{"given":"Manuela","family":"Carvalheiro","sequence":"additional","affiliation":[{"name":"Departments of Endocrinology, Diabetes, and Metabolism (M.Me., F.C., M.C.), 3000-075 Coimbra, Portugal"},{"name":"Unit of Endocrinology (M.Me., M.C.), Faculty of Medicine, University of Coimbra, 3000-548 Coimbra, Portugal"}]},{"given":"Valdemar","family":"M\u00e1ximo","sequence":"additional","affiliation":[{"name":"Institute of Molecular Pathology and Immunology of the University of Porto (M.Me., A.G.d.R., J.V., R.B., J.P., C.T., R.C., A.A., C.S., C.E., P.C., H.P., J.L., V.M., M.S.-S., P.S.), 4200-465 Porto, Portugal"},{"name":"Department of Pathology and Oncology, Medical Faculty, University of Porto (J.L., V.M., M.S.-S., P.S.), 4200-139 Porto, Portugal"}]},{"given":"Manuel","family":"Sobrinho-Sim\u00f5es","sequence":"additional","affiliation":[{"name":"Institute of Molecular Pathology and Immunology of the University of Porto (M.Me., A.G.d.R., J.V., R.B., J.P., C.T., R.C., A.A., C.S., C.E., P.C., H.P., J.L., V.M., M.S.-S., P.S.), 4200-465 Porto, Portugal"},{"name":"Department of Pathology and Oncology, Medical Faculty, University of Porto (J.L., V.M., M.S.-S., P.S.), 4200-139 Porto, Portugal"},{"name":"Department of Pathology (M.S.-S.), Hospital S. Jo\u00e3o, 4200-319 Porto, Portugal"}]},{"given":"Paula","family":"Soares","sequence":"additional","affiliation":[{"name":"Institute of Molecular Pathology and Immunology of the University of Porto (M.Me., A.G.d.R., J.V., R.B., J.P., C.T., R.C., A.A., C.S., C.E., P.C., H.P., J.L., V.M., M.S.-S., P.S.), 4200-465 Porto, Portugal"},{"name":"Department of Pathology and Oncology, Medical Faculty, University of Porto (J.L., V.M., M.S.-S., P.S.), 4200-139 Porto, Portugal"}]}],"member":"80","reference":[{"key":"key\n\t\t\t\t2019041113350021900_B1","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The hallmarks of cancer","volume":"100","author":"Hanahan","year":"2000","journal-title":"Cell"},{"key":"key\n\t\t\t\t2019041113350021900_B2","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1126\/science.7605428","article-title":"Specific association of human telomerase activity with immortal cells and cancer","volume":"266","author":"Kim","year":"1994","journal-title":"Science"},{"key":"key\n\t\t\t\t2019041113350021900_B3","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0959-8049(97)00062-2","article-title":"A survey of telomerase activity in human cancer","volume":"33","author":"Shay","year":"1997","journal-title":"Eur J Cancer"},{"key":"key\n\t\t\t\t2019041113350021900_B4","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1038\/nm1197-1271","article-title":"Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines","volume":"3","author":"Bryan","year":"1997","journal-title":"Nat Med"},{"key":"key\n\t\t\t\t2019041113350021900_B5","doi-asserted-by":"crossref","first-page":"4240","DOI":"10.1002\/j.1460-2075.1995.tb00098.x","article-title":"Telomere elongation in immortal human cells without detectable telomerase activity","volume":"14","author":"Bryan","year":"1995","journal-title":"EMBO J"},{"key":"key\n\t\t\t\t2019041113350021900_B6","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0950-351X(10)80012-6","article-title":"Growth factors controlling the thyroid gland","volume":"5","author":"Dumont","year":"1991","journal-title":"Baillieres Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113350021900_B7","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/modpathol.3800124","article-title":"Telomerase expression and proliferative activity suggest a stem cell role for thyroid solid cell nests","volume":"17","author":"Preto","year":"2004","journal-title":"Mod Pathol"},{"key":"key\n\t\t\t\t2019041113350021900_B8","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/path.848","article-title":"Telomerase activity and telomere length in thyroid neoplasia: biological and clinical implications","volume":"194","author":"Matthews","year":"2001","journal-title":"J Pathol"},{"key":"key\n\t\t\t\t2019041113350021900_B9","doi-asserted-by":"crossref","first-page":"609","DOI":"10.2174\/138920211798120853","article-title":"Genetic alterations in poorly differentiated and undifferentiated thyroid carcinomas","volume":"12","author":"Soares","year":"2011","journal-title":"Curr Genomics"},{"key":"key\n\t\t\t\t2019041113350021900_B10","doi-asserted-by":"crossref","first-page":"E1327","DOI":"10.1210\/jc.2011-2096","article-title":"Telomere abnormalities and chromosome fragility in patients affected by familial papillary thyroid cancer","volume":"97","author":"Cantara","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113350021900_B11","doi-asserted-by":"crossref","first-page":"E1852","DOI":"10.1210\/jc.2011-1003","article-title":"Telomere length in neoplastic and nonneoplastic tissues of patients with familial and sporadic papillary thyroid cancer","volume":"96","author":"Capezzone","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113350021900_B12","first-page":"265","article-title":"Expression of telomerase genes in thyroid carcinoma","volume":"21","author":"Hoang-Vu","year":"2002","journal-title":"Int J Oncol"},{"key":"key\n\t\t\t\t2019041113350021900_B13","first-page":"715","article-title":"Quantitative measurement of telomerase reverse transcriptase, thyroglobulin and thyroid transcription factor 1 mRNAs in anaplastic thyroid carcinoma tissues and cell lines","volume":"18","author":"Takano","year":"2007","journal-title":"Oncol Rep"},{"key":"key\n\t\t\t\t2019041113350021900_B14","first-page":"4214","article-title":"Telomerase activity in human thyroid carcinomas originating from the follicular cells","volume":"82","author":"Brousset","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113350021900_B15","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1038\/ncomms3185","article-title":"Frequency of TERT promoter mutations in human cancers","volume":"4","author":"Vinagre","year":"2013","journal-title":"Nat Commun"},{"key":"key\n\t\t\t\t2019041113350021900_B16","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1126\/science.1230062","article-title":"TERT promoter mutations in familial and sporadic melanoma","volume":"339","author":"Horn","year":"2013","journal-title":"Science"},{"key":"key\n\t\t\t\t2019041113350021900_B17","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1126\/science.1229259","article-title":"Highly recurrent TERT promoter mutations in human melanoma","volume":"339","author":"Huang","year":"2013","journal-title":"Science"},{"key":"key\n\t\t\t\t2019041113350021900_B18","doi-asserted-by":"crossref","first-page":"6021","DOI":"10.1073\/pnas.1303607110","article-title":"TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal","volume":"110","author":"Killela","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t2019041113350021900_B19","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1530\/ERC-13-0210","article-title":"Highly prevalent TERT promoter mutations in aggressive thyroid cancers","volume":"20","author":"Liu","year":"2013","journal-title":"Endocr Related Cancer"},{"key":"key\n\t\t\t\t2019041113350021900_B20","doi-asserted-by":"crossref","first-page":"E1562","DOI":"10.1210\/jc.2013-2383","article-title":"Frequent somatic TERT promoter mutations in thyroid cancer: higher prevalence in advanced forms of the disease","volume":"98","author":"Landa","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113350021900_B21","volume-title":"WHO Classification of Tumours. Pathology and Genetics of Tumours of Endocrine Organs","author":"DeLellis","year":"2004"},{"key":"key\n\t\t\t\t2019041113350021900_B22","doi-asserted-by":"crossref","first-page":"4267","DOI":"10.1210\/jc.2003-032224","article-title":"BRAF mutations are not a major event in post-Chernobyl childhood thyroid carcinomas","volume":"89","author":"Lima","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113350021900_B23","doi-asserted-by":"crossref","first-page":"4578","DOI":"10.1038\/sj.onc.1206706","article-title":"BRAF mutations and RET\/PTC rearrangements are alternative events in the etiopathogenesis of PTC","volume":"22","author":"Soares","year":"2003","journal-title":"Oncogene"},{"key":"key\n\t\t\t\t2019041113350021900_B24","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00428-005-1236-0","article-title":"Type and prevalence of BRAF mutations are closely associated with papillary thyroid carcinoma histotype and patients' age but not with tumour aggressiveness","volume":"446","author":"Trovisco","year":"2005","journal-title":"Virchows Arch"},{"key":"key\n\t\t\t\t2019041113350021900_B25","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1111\/j.1365-2559.2012.04276.x","article-title":"RET\/PTC rearrangement is prevalent in follicular Hurthle cell carcinomas","volume":"61","author":"de Vries","year":"2012","journal-title":"Histopathology"},{"key":"key\n\t\t\t\t2019041113350021900_B26","article-title":"The age- and shorter telomere-dependent TERT promoter mutation in follicular thyroid cell-derived carcinomas [published online October 21, 2013]","author":"Liu","journal-title":"Oncogene"},{"key":"key\n\t\t\t\t2019041113350021900_B27","doi-asserted-by":"crossref","first-page":"E981","DOI":"10.1210\/jc.2012-4006","article-title":"DNA microarray and miRNA analyses reinforce the classification of follicular thyroid tumors","volume":"98","author":"Jacques","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113350021900_B28","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1210\/jc.2009-1536","article-title":"Are the clinical and pathological features of differentiated thyroid carcinoma really changed over the last 35 years? Study on 4187 patients from a single Italian institution to answer this question","volume":"95","author":"Elisei","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"key\n\t\t\t\t2019041113350021900_B29","doi-asserted-by":"crossref","first-page":"E276","DOI":"10.1210\/jc.2013-2503","article-title":"The increase in thyroid cancer incidence during the last four decades is accompanied by a high frequency of BRAF mutations and a sharp increase in RAS mutations","volume":"99","author":"Jung","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113350021900_B30","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1002\/(SICI)1097-0142(19981215)83:12<2638::AID-CNCR31>3.0.CO;2-1","article-title":"A National Cancer Data Base report on 53 856 cases of thyroid carcinoma treated in the US, 1985\u20131995","volume":"83","author":"Hundahl","year":"1998","journal-title":"Cancer"},{"key":"key\n\t\t\t\t2019041113350021900_B31","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1002\/cncr.22956","article-title":"Clinical management and outcome of papillary and follicular (differentiated) thyroid cancer presenting with distant metastasis at diagnosis","volume":"110","author":"Sampson","year":"2007","journal-title":"Cancer"},{"key":"key\n\t\t\t\t2019041113350021900_B32","volume-title":"UICC: TNM Classification of Malignant Tumors","author":"Sobin","year":"2002","edition":"6th ed"},{"key":"key\n\t\t\t\t2019041113350021900_B33","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1089\/thy.2012.0269","article-title":"Multivariate analysis of the relationship between male sex, disease-specific survival, and features of tumor aggressiveness in thyroid cancer of follicular cell origin","volume":"23","author":"Nilubol","year":"2013","journal-title":"Thyroid"},{"key":"key\n\t\t\t\t2019041113350021900_B34","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1001\/jama.2013.3190","article-title":"Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer","volume":"309","author":"Xing","year":"2013","journal-title":"JAMA"},{"key":"key\n\t\t\t\t2019041113350021900_B35","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1634\/theoncologist.12-1-20","article-title":"Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program","volume":"12","author":"Hayat","year":"2007","journal-title":"Oncologist"},{"key":"key\n\t\t\t\t2019041113350021900_B36","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1056\/NEJMoa1109589","article-title":"Ablation with low-dose radioiodine and thyrotropin \u03b1 in thyroid cancer","volume":"366","author":"Mallick","year":"2012","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041113350021900_B37","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1056\/NEJMoa1108586","article-title":"Strategies of radioiodine ablation in patients with low-risk thyroid cancer","volume":"366","author":"Schlumberger","year":"2012","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041113350021900_B38","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.clon.2012.01.001","article-title":"Iodine or Not (IoN) for low-risk differentiated thyroid cancer: the next UK National Cancer Research Network randomised trial following HiLo","volume":"24","author":"Mallick","year":"2012","journal-title":"Clin Oncol"},{"key":"key\n\t\t\t\t2019041113350021900_B39","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1111\/j.1349-7006.2012.02410.x","article-title":"Antitumor effect of new multiple antigen peptide based on HLA-A0201-restricted CTL epitopes of human telomerase reverse transcriptase (hTERT)","volume":"103","author":"Liao","year":"2012","journal-title":"Cancer Sci"},{"key":"key\n\t\t\t\t2019041113350021900_B40","doi-asserted-by":"crossref","first-page":"e23430","DOI":"10.4161\/onci.23430","article-title":"Universal tumor-reactive helper peptides from telomerase as new tools for anticancer vaccination","volume":"2","author":"Dosset","year":"2013","journal-title":"Oncoimmunology"},{"key":"key\n\t\t\t\t2019041113350021900_B41","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ccr.2012.02.022","article-title":"Accessories to the crime: functions of cells recruited to the tumor microenvironment","volume":"21","author":"Hanahan","year":"2012","journal-title":"Cancer Cell"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/99\/5\/E754\/9050440\/jcemE754.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T03:56:51Z","timestamp":1565150211000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/99\/5\/E754\/2537729"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,1]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,5,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2013-3734","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,1]]}}}